Antimicrobial resistance (AMR) is a significant public health concern worldwide. AMR has become a global public health concern since the introduction of antibiotic resistance in the 2000s, with the increasing global demand for effective treatment options []. The global impact of AMR is an urgent need for new treatment options and antimicrobial drug discovery []. In this review, we will focus on two commonly used antimicrobial antibiotics, tetracycline (TC) and minocycline (MOC), and discuss their mechanisms of action, mechanism of action, therapeutic targets, and potential therapeutic uses. We will focus on the role of tetracycline and its analogues (TCA and MOC), and on the importance of the tetracycline antibiotic in drug-drug interactions.
Tetracycline is a broad-spectrum antibiotic, belonging to the tetracycline family. It is effective against a wide range of Gram-positive and Gram-negative bacteria []. Its pharmacokinetic properties, including its bioavailability, tissue penetration, and bioavailability in healthy tissues, as well as its ability to penetrate the gastrointestinal tract, are well established in clinical practice [, ]. Tetracycline has also been demonstrated to have activity against a variety of Gram-negative and Gram-positive bacteria, including Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae []. Its mode of action is related to its ability to inhibit bacterial protein synthesis, which is essential for the survival and growth of many microorganisms []. Tetracycline is classified as a tetracycline analogue, with the main mode of action of this class of antibiotics being as a tetracycline analogue with the primary mode of action (amino acid substitution at the 3-position). It is a broad-spectrum antibiotic with a broad-spectrum activity against a variety of Gram-negative and Gram-positive microorganisms [, ]. Tetracycline is a synthetic derivative of the amino acid phenylalanine (α-tetracycline), which is known to have an anti-proliferative activity []. In a clinical study, tetracycline was shown to exhibit anti-cancer activity against breast cancer, prostate cancer, and ovarian cancer, especially against a variety of cancers such as endometrial and ovarian cancer [].
Tetracycline is an analogue of tetracycline (TC) and acts by inhibiting bacterial protein synthesis, thereby disrupting the bacterial cell wall. This mechanism is essential for the cell wall integrity and bacterial cell division []. Tetracycline has a similar affinity to the β-lactamase enzyme []. The inhibitory effect of Tetracycline on the expression of the β-lactamase enzyme in Gram-positive and Gram-negative bacteria is mediated by the reduction of β-lactamase activity []. The β-lactamase is a type I β-lactamase that has activity against Gram-positive bacteria, but is not capable of inhibiting bacterial cell wall synthesis. The β-lactamase is responsible for the hydrolysis of β-lactamic acid into the β-lactamic acid monohydrate, which has antibacterial activity against Gram-positive bacteria. This leads to the accumulation of the β-lactamic acid in the bacterial cell membrane and disruption of the bacterial DNA synthesis. The mechanism of action of Tetracycline in bacteria is complicated. Tetracycline is a synthetic derivative of the amino acid phenylalanine, which has antimicrobial activity against a wide range of bacteria [, ]. Tetracycline has a similar affinity to the β-lactamase enzyme and binds to the same sites in the bacterial cell wall, leading to inhibition of the bacterial cell wall []. In addition, the inhibition of the β-lactamase in bacteria results in an accumulation of the β-lactamase, which is necessary for the bacterial cell wall integrity, the cell division cycle, and the survival of the microorganisms [].
In addition to its antimicrobial activity, Tetracycline has a broad spectrum of applications for research in medicine []. In general, Tetracycline is used as an antimalarial, antiprotozoal, and bacteriostatic drug, with a broad spectrum of applications, including in the treatment of infectious diseases such as tuberculosis, bronchitis, and pneumonia. The development of the tetracycline derivative (TCA) has been a promising field for drug development [, ].
Tetracycline is an antibiotic, which belongs to a group of medicines known as tetracyclines. It is used to treat a variety of infections caused by bacteria. It may also be used in the treatment of certain kinds of acne.
Tetracycline may be given as a pill, capsule, or syringe. The dosage and administration of this medicine are based on your medical condition and response to treatment. Dosages and administration instructions are given in the label.
Tetracycline should not be used during pregnancy. It can harm the developing fetus. This medicine is not recommended for use during pregnancy.
Tetracycline may cause dizziness and headaches, especially when used with alcohol and other CNS depressants. If this occurs, use caution. If dizziness occurs, use caution. If you experience blurred vision or other side effects, contact your doctor.
Tetracycline may interact with other medications. Tell your doctor about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Be sure to tell your doctor and pharmacist about all the drugs you take, including over-the-counter medicines, vitamins, and herbal supplements.
Tetracycline can cause dizziness and headaches, especially when used with alcohol and other CNS depressants.
Tell your doctor and pharmacist about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
See.
It is used to treat a variety of infections. It can also be used to treat other types of infections.
Save16%
Original price$ 319.00
Current price$ 269.00
SKU23155-0767-01
Medical Professional License Required to Unlock Account(Note: We don’t Fill Personal Prescriptions)How to Order:
✔Send an email request to: [email protected]
You will receive instructions on how to create an account along with Rx Ordering Details.
Tetracycline HCl Capsules USP 500 mg is an antibiotic medication used to treat a variety of bacterial infections, including respiratory tract infections, skin infections, and urinary tract infections. It belongs to a class of antibiotics called tetracyclines, which work by preventing the growth and spread of bacteria. This medication should only be used to treat bacterial infections and will not work for viral infections such as the common cold or flu. Tetracycline HCl Capsules USP 500 mg is a prescription medication used to treat bacterial infections, including those involving the skin, respiratory tract, urinary tract, and digestive system. It can also be used to treat certain sexually transmitted infections and other conditions as determined by a doctor. The capsules are usually taken orally and the dosage and length of treatment will depend on the specific infection being treated. It is important to finish the full course of treatment prescribed by the doctor, even if the symptoms improve. It is important to take Tetracycline HCl Capsules USP 500 mg on an empty stomach (at least one hour before or two hours after meals) with a full glass of water. This medication should not be taken with dairy products, antacids, or iron supplements, as they can decrease the effectiveness of the medication. If the medication is being used to treat an infection, symptoms should start to improve within a few days. However, it is important to continue taking the medication for the prescribed length of time to ensure that the infection is fully treated and to prevent bacteria from becoming resistant to the antibiotic. If a dose is missed, it should be taken as soon as possible. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule should be resumed. Tetracycline HCl Capsules USP 50 mg may interact with other medications and supplements, so it is important to inform the doctor of any other medications being taken. It is also important to let the doctor know if there are any allergies to tetracycline or other antibiotics. Possible side effects of Tetracycline HCl Capsules USP 500 mg include nausea, vomiting, stomach upset, diarrhea, loss of appetite, and headache. If these side effects are severe or persistent, it is important to inform the doctor. If any serious side effects occur, such as difficulty breathing, yellowing of the skin or eyes, or symptoms of a severe allergic reaction, seek medical attention immediately. It is important to complete the full prescribed course of treatment for Tetracycline HCl Capsules USP 500 mg, even if symptoms improve, in order to fully eradicate the infection and prevent bacteria from becoming resistant to the medication.
Read More AboutTetracycline HCl Capsules USP 500 mg is a prescription medication used to treat bacterial infections, including those involving the skin, respiratory tract, skin infection, urinary tract infection, and digestive tract. It should be taken orally and the dosage and length of treatment will be determined by the doctor. It is important to complete the full course of treatment prescribed by the doctor, even if symptoms improve within a few days, as it is important to finish the entire course of treatment. It is important to finish the entire course of treatment in a few days, even if symptoms improve. It is important to finish the entire course of treatment even if symptoms improve without medications. It is important to complete the full course of treatment prescribed by the doctor, even if the symptoms improve before the infection is completely treated. It is important to complete the course of Tetracycline HCl Capsules USP 500 mg prescribed by the doctor, even if the symptoms improve without medications. It is important to complete the prescribed dose even if the symptoms improve without medications.
This study was performed to evaluate the effects of tetracycline (Tetracycline, 100 micrograms/mL) and doxycycline (Dox, 100 micrograms/mL) on the growth ofEscherichia colistrainE. coliATCCKi1(S.n.).Tetracycline and doxycycline treatment ofstrain ATCC 63384 at 30-day intervals for up to 14 days were carried out in two types of in vitro growth media: an medium containing 0.2% Tetracycline (pH = 8) and a medium containing 0.1% Dox (pH = 8).
strain ATCC 63384 (10, 30 and 100 mg/L) was used as a growth substrate. At 30-day intervals (24, 48, 72 and 96 hours) the growth rate was assessed by the microdilution method using an agar plate and compared with the control medium (pH 8).
The growth inhibition was defined as the inhibition of the growth of the bacteria by the growth substrate Tetracycline (100 micrograms/mL) and Dox (100 micrograms/mL).In order to determine the effect of Tetracycline and Dox on the growth ofstrain ATCC 63384, the following experiments were carried out using media containing 0.2% Tetracycline (pH = 8), 0.1% Dox (pH = 8) and 0.1% Tetracycline (pH = 8) alone, or in combination with 0.1% Dox (pH = 8), or in combination with 0.1% Tetracycline (pH = 8) alone. Tetracycline and Dox were added to the growth media at 0.3, 0.5, 1, 2 and 3 hours, respectively, after which the incubation was performed by agar-slinging the plates in the absence and presence of 0.2% Tetracycline (pH = 8) and 0.1% Dox (pH = 8) alone. At 24 hours the growth rate was determined using an agar plate. The minimum inhibitory concentration (MIC) values of the antibiotics were obtained using an agar plate. Dox was added to the growth medium (0.3 and 0.5 mg/mL). Growth rate was determined using an agar plate.
Susceptibility tests were performed at 30-day intervals in accordance with Clinical and Laboratory Standards Institute (CLSI) guidelines (E-EXPAT) and following the CLSI guidelines.The MICs of Tetracycline and Dox were determined using a microdilution method according to CLSI guidelines.strain ATCC 63384, the following experiments were carried out using media containing 0.2% Tetracycline (pH = 8), 0.1% Dox (pH = 8) and 0.1% Tetracycline (pH = 8) alone, or in combination with 0.2% Tetracycline (pH = 8) alone.
Susceptibility test forATCC 63384andATCC 63384 (10, 30 and 100 mg/L) were used to determine the effect of the antibiotic on the growth of
Vasco JM, Coughlin H, Stough P, et al. (eds).Chemical structure of tetracycline and related antibiotics: A review. In:Chemical Data. 2nd ed. Philadelphia: Elsevier; 2007:1–11
Rosen H, Gansler C, Tiwari M, et al.Chemical structures of tetracyclines and related antibiotics: A review.Philadelphia: Elsevier; 2007:1–16
Bakker E, Eriksson S, Gershorn D, et al.Chemical structure of antibiotics: A review.Philadelphia: Elsevier; 2007:1–14
Pfizer P, Bajaj N, Krantz A, et al.Chemical structure of tetracycline: A review.Philadelphia: Elsevier; 2007:1–18
Sidoli A, Lederle N, Baud C, et al.Chemical structure of tetracyclines: A review.
Hendryt J, Whelmina A, Eriksson S, et al.
Philadelphia: Elsevier; 2007:1–22
Jättner S, Karpman J, Uppas B, et al.
Szluj L, Soszczowski P, Zdziwillnak S, et al.Philadelphia: Elsevier; 2007:1–12
Alfani S, Gershorn D, Stough P, et al.Philadelphia: Elsevier; 2007:1–13
Mullen H, Loder M, Sartor I, et al.
Bai J, Chiu J, Lader K, et al.
Stade de France Pharmacy